The bill s164-117 would require the FDA to expand education and awareness programs for healthcare providers about biological products and biosimilars within the Pharmaceuticals & Biotech industry. Senator Margaret Wood Hassan (D-NH) introduced this bill. Pharmaceuticals & Biotech accounts for 1.6% of Hassan's identifiable donations ($0.63M), ranking 87th among donor industries within her party.

FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated June 30, 2026 · internal signal score 40/100.